Condition: Ischemic Stroke · Large Vessel Occlusion · Endovascular Treatment · Sponsor: University of Freiburg
The goal of this clinical trial is to test the combination of hypothermia and endovascular treatment in acute stroke patients with large vessel occlusion. The main question it aims to answer is: does an additional cooling to 35°C result in a benefit on clinical outcome ? Participants receive immediate cooling using a noninvasive transnasal cooling technique (RhonoChill) and are maintained at 35°C for 6 hours after reopening of the vessel using surface cooling, and then slowly rewarmed. Researchers will compare the intervention group (hypothermia and endovascular treatment and best medical treatment including iv thrombolysis) and control group (only endovascular treatment and best medical treatment including iv thrombolysis) to see if additional hypothermia leads to a better outcome after 3 months without relevant complications.
This description comes directly from the study's public registry record.
Juergen Bardutzky, Prof. · +49-15237729739 · juergen.bardutzky@uniklinik-freiburg.de
Wolf-Dirk Niesen, PD Dr. · 0049-761-270-53050 · wolf-dirk.niesen@uniklinik-freiburg.de
Always discuss trial participation with your own doctor first.
| University of Freiburg, Department of Neurology | Freiburg im Breisgau, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06301412